Nasal allergies and beyond: a clinical review of the pharmacology, efficacy, and safety of mometasone furoate

被引：0
作者：
van Drunen, C
Meltzer, EO
Bachert, C
Bousquet, J
Fokkens, WJ
机构：
[1] Univ Amsterdam, Acad Med Ctr, Dept Otorhinolaryngol, NL-1100 DD Amsterdam, Netherlands
[2] Allergy & Asthma Med Grp & Res Ctr, San Diego, CA USA
[3] Ghent Univ Hosp, ENT Dept, B-9000 Ghent, Belgium
[4] Cent Hosp Univ, Hop Arnaud de Villeneuve, Dept Resp Dis, Montpellier, France
来源：
ALLERGY | 2005年 / 60卷
关键词：
mometasone furoate; allergic rhinitis; nasal allergies; intranasal corticosteroids;
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
Mometasone furoate nasal spray (MFNS; Nasonex(R), Schering-Plough Corporation, Kenilworth, NJ, USA) is an effective and well-tolerated intranasal corticosteroid approved for the prophylactic treatment of seasonal allergic rhinitis, and the treatment of perennial allergic rhinitis. MFNS is a potent molecule with a rapid onset of action and excellent safety and efficacy profiles. Having recently received approval for the treatment of nasal polyposis, data indicate that MFNS may also be effective in rhinosinusitis.
引用
收藏
页码：5 / 19
页数：15
相关论文
共 50 条
  • [1] Efficacy and safety of mometasone furoate nasal spray in nasal polyposis
    Small, CB
    Hernandez, J
    Reyes, A
    Schenkel, E
    Damiano, A
    Stryszak, P
    Staudinger, H
    Danzig, M
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 116 (06) : 1275 - 1281
  • [2] Pharmacokinetic/pharmacodynamic profile of mometasone furoate nasal spray: Potential effects on clinical safety and efficacy
    Hochhaus, Guenther
    CLINICAL THERAPEUTICS, 2008, 30 (01) : 1 - 13
  • [3] THE RELEVANCE OF THE MOMETASONE FUROATE NASAL SPRAY IN CLINICAL PRACTICE
    Ciprandi, G.
    Varricchio, A.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2018, 32 (04) : 1051 - 1054
  • [4] Mometasone furoate nasal spray - A review of safety and systemic effects
    Zitt, Myron
    Kosoglou, Teddy
    Hubbell, James
    DRUG SAFETY, 2007, 30 (04) : 317 - 326
  • [5] Mometasone furoate nasal spray: a systematic review
    Passali, Desiderio
    Spinosi, Maria Carla
    Crisanti, Anna
    Bellussi, Luisa Maria
    MULTIDISCIPLINARY RESPIRATORY MEDICINE, 2016, 11
  • [6] Mometasone Furoate Nasal SprayA Review of Safety and Systemic Effects
    Myron Zitt
    Teddy Kosoglou
    James Hubbell
    Drug Safety, 2007, 30 : 317 - 326
  • [7] Comparative clinical pharmacology of mometasone furoate, fluticasone propionate and fluticasone furoate
    Daley-Yates, Peter T.
    Deans, Amanda
    Mehta, Rashmi
    Sousa, Ana R.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2022, 77
  • [8] Safety and efficacy of mometasone furoate aqueous nasal spray in children with allergic rhinitis: Results of recent clinical trials
    Dibildox, J
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 108 (01) : S54 - S58
  • [9] Efficacy and Safety of the Combination Nasal Spray Olopatadine Hydrochloride-Mometasone Furoate in the Treatment of allergic Rhinitis
    Klimek, Ludger
    Klimek, Felix
    Bergmann, Christoph
    Hagemann, Jan
    Cuevas, Mandy
    Becker, Sven
    ALLERGO JOURNAL, 2024, 33 (01) : 31 - 43
  • [10] Efficacy and safety of a new mometasone furoate nasal spray formulation in patients with acute rhinosinusitis: a randomized clinical trial
    Mehmood, Yasir
    Shahid, Hira
    Tariq, Aysha
    Ali, Syeda Omama
    ITALIAN JOURNAL OF MEDICINE, 2022, 16 (01) : 10 - 14
12345